May 13, 2026
Alert: Notice Regarding Schedule II CDS Telemedicine Prescriptions for Certain Patients
The Division of Consumer Affairs (Division) issues this guidance to clarify the requirements governing the prescribing of Schedule II controlled dangerous substances via telemedicine or telehealth to certain patients.